跳到正文
Isomorphic Labs·· 2026-05-12精选AI 评分78

Isomorphic Labs 完成 2.1B 美元 B 轮融资

Isomorphic Labs announces Series B investment round

AI 导读

Isomorphic Labs 宣布完成 2.1B 美元 B 轮融资,由 Thrive Capital 领投。现有投资方 Alphabet 和 GV 继续参与,新投资方包括 MGX、Temasek、CapitalG 和英国主权 AI 基金。公司称资金将用于支持其 AI 药物设计引擎 IsoDDE、全球业务扩张和药物候选管线推进。

推荐理由

这笔 2.1B 美元融资给出了 AI 药物设计公司的资金规模与投资方阵容,可对照其管线推进节奏。

正文 · 原文

Isomorphic Labs announces it has raised $2.1 Billion in Series B funding. The financing round is led by Thrive Capital, and includes participation from existing backers Alphabet and GV alongside new investors MGX, Temasek, CapitalG, and the UK Sovereign AI Fund, significantly expanding Isomorphic Labs’ global capital base.

Isomorphic Labs was founded with the ambition to leverage the power of AI to reimagine and accelerate drug discovery to bring much-needed treatments to millions of patients globally. The company aims to apply its pioneering AI drug design engine (IsoDDE) to deliver biomedical breakthroughs and is advancing drug design programs across multiple therapeutic areas and drug modalities.

Read more in the news release below.

‍

Isomorphic Labs announces

$2.1 Billion funding to power its world-leading AI drug design engine, scale its business globally and progress its drug candidate pipeline.

Read more

来源:Isomorphic Labs · isomorphiclabs.com